Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NPS raises $170 million

NPS (NPSP; TSE:NX) raised $170 million in a bumped-up note deal. The

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE